MIRAMAR, Fla.--(BUSINESS WIRE)--
Altor BioScience Corporation (Altor), a leading developer of cancer immunotherapeutics, announced today that it has named Dr. Patrick Soon-Shiong, a well-known physician scientist and inventor of Abraxane, an albumin-bound nanoparticle of paclitaxel approved for breast, lung and pancreatic cancer, as Chairman of Altor’s Board of Directors.
Altor BioScience Corporation (Altor), a leading developer of cancer immunotherapeutics, announced today that it has named Dr. Patrick Soon-Shiong, a well-known physician scientist and inventor of Abraxane, an albumin-bound nanoparticle of paclitaxel approved for breast, lung and pancreatic cancer, as Chairman of Altor’s Board of Directors.
